Trexquant Investment’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.07M | Buy |
91,633
+75,969
| +485% | +$1.69M | 0.01% | 980 |
|
|
2025
Q4 | $405K | Sell |
15,664
-44,432
| -74% | -$1.06M | ﹤0.01% | 1386 |
|
|
2025
Q3 | $1.55M | Buy |
+60,096
| New | +$1.48M | 0.02% | 1002 |
|
|
2025
Q1 | – | Sell |
-198,090
| Closed | -$3.73M | – | 1787 |
|
|
2024
Q4 | $3.73M | Sell |
198,090
-315,007
| -61% | -$5.53M | 0.04% | 628 |
|
|
2024
Q3 | $7.72M | Buy |
513,097
+346,125
| +207% | +$5.92M | 0.1% | 317 |
|
|
2024
Q2 | $4.78M | Buy |
166,972
+142,968
| +596% | +$4.07M | 0.07% | 417 |
|
|
2024
Q1 | $701K | Buy |
+24,004
| New | +$737K | 0.01% | 1045 |
|
|
2023
Q4 | – | Sell |
-15,845
| Closed | -$486K | – | 1697 |
|
|
2023
Q3 | $486K | Buy |
+15,845
| New | +$571K | 0.01% | 1035 |
|
|
2023
Q2 | – | Sell |
-27,863
| Closed | -$1.14M | – | 1708 |
|
|
2023
Q1 | $1.14M | Sell |
27,863
-14,182
| -34% | -$564K | 0.03% | 687 |
|
|
2022
Q4 | $1.62M | Buy |
+42,045
| New | +$2.05M | 0.05% | 487 |
|
|
2022
Q3 | – | Sell |
-4,662
| Closed | -$272K | – | 1734 |
|
|
2022
Q2 | $272K | Buy |
+4,662
| New | +$305K | 0.01% | 1174 |
|
|
2020
Q1 | – | Sell |
-4,533
| Closed | -$205K | – | 1338 |
|
|
2019
Q4 | $205K | Buy |
+4,533
| New | +$193K | 0.01% | 902 |
|
|
2019
Q3 | – | Sell |
-27,502
| Closed | -$1.2M | – | 1054 |
|
|
2019
Q2 | $1.2M | Buy |
27,502
+14,035
| +104% | +$596K | 0.11% | 272 |
|
|
2019
Q1 | $513K | Sell |
13,467
-12,029
| -47% | -$469K | 0.04% | 582 |
|
|
2018
Q4 | $1.1M | Buy |
25,496
+15,171
| +147% | +$708K | 0.07% | 405 |
|
|
2018
Q3 | $507K | Sell |
10,325
-30,440
| -75% | -$1.32M | 0.04% | 534 |
|
|
2018
Q2 | $1.31M | Buy |
+40,765
| New | +$1.41M | 0.09% | 313 |
|
|
2018
Q1 | – | Sell |
-14,246
| Closed | -$650K | – | 1300 |
|
|
2017
Q4 | $650K | Buy |
14,246
+8,662
| +155% | +$343K | 0.07% | 413 |
|
|
2017
Q3 | $210K | Buy |
5,584
+684
| +14% | +$27.5K | 0.05% | 613 |
|
|
2017
Q2 | $234K | Sell |
4,900
-300
| -6% | -$13.9K | 0.06% | 591 |
|
|
2017
Q1 | $237K | Buy |
+5,200
| New | +$225K | 0.03% | 884 |
|
|
2016
Q4 | – | Sell |
-20,800
| Closed | -$712K | – | 1101 |
|
|
2016
Q3 | $712K | Buy |
+20,800
| New | +$815K | 0.16% | 205 |
|
|
2015
Q2 | – | Sell |
-11,300
| Closed | -$1M | – | 1174 |
|
|
2015
Q1 | $1M | Buy |
+11,300
| New | +$1.15M | 0.1% | 363 |
|
Other funds holding PCRX
DPCM
VPM
VCM